Literature DB >> 21107788

[Multimodality treatment concepts for metastatic breast cancer].

V Heinemann1, S Kahlert, H-J Stemmler.   

Abstract

While metastatic breast cancer is a systemic disease in most patients, there is a smaller subset of patients who suffer from oligometastatic disease defined by single or few resectable metastases. After verification of disease stabilization by systemic therapy, locoregional treatment such as surgery or radiation can be applied. While large prospective trials are missing to support the beneficial effect of this strategy, retrospective analyses are highly suggestive offering rapid disease control and even long-term survival in selected patients.

Entities:  

Mesh:

Year:  2010        PMID: 21107788     DOI: 10.1007/s00108-010-2676-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  29 in total

1.  Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy.

Authors:  M Ryberg; D Nielsen; K Osterlind; T Skovsgaard; P Dombernowsky
Journal:  Ann Oncol       Date:  2001-01       Impact factor: 32.976

Review 2.  Liver metastases: interventional therapeutic techniques and results, state of the art.

Authors:  T J Vogl; P K Müller; M G Mack; R Straub; K Engelmann; P Neuhaus
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

3.  Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients.

Authors:  T Livraghi; S N Goldberg; L Solbiati; F Meloni; T Ierace; G S Gazelle
Journal:  Radiology       Date:  2001-07       Impact factor: 11.105

4.  Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma.

Authors:  T Shibata; T Niinobu; N Ogata; M Takami
Journal:  Cancer       Date:  2000-07-15       Impact factor: 6.860

5.  The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases.

Authors:  Steve R Martinez; Shawn E Young; Armando E Giuliano; Anton J Bilchik
Journal:  Am J Surg       Date:  2006-02       Impact factor: 2.565

Review 6.  Surgical resection of liver metastases from breast cancer.

Authors:  Emilie Lermite; Ettore Marzano; Elisabeth Chéreau; Roman Rouzier; Patrick Pessaux
Journal:  Surg Oncol       Date:  2009-07-09       Impact factor: 3.279

Review 7.  Recurrent breast cancer: presentation, diagnosis, and treatment.

Authors:  L Jardines; L S Callans; M H Torosian
Journal:  Semin Oncol       Date:  1993-10       Impact factor: 4.929

Review 8.  An attempt to clarify indications for hepatectomy for liver metastases from breast cancer.

Authors:  Dominique Elias; Franck Maisonnette; Michel Druet-Cabanac; Jean Francois Ouellet; Jean Marc Guinebretiere; Marc Spielmann; Suzette Delaloge
Journal:  Am J Surg       Date:  2003-02       Impact factor: 2.565

9.  Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver.

Authors:  Luis H Camacho; Razelle Kurzrock; Alex Cheung; Diane F Barber; Sanjay Gupta; David C Madoff; Michael J Wallace; E Edmund Kim; Steven A Curley; Gabriel N Hortobagyi; Giora Mavligit
Journal:  Cancer       Date:  2007-06-01       Impact factor: 6.860

Review 10.  Hepatic complications of breast cancer.

Authors:  Jennifer R Diamond; Christina A Finlayson; Virginia F Borges
Journal:  Lancet Oncol       Date:  2009-06       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.